An interventional study of Home treatment and Treatment As Usual in Mental Disorders, sponsored by Psychiatric Services Aargau AG. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2018-06-06.
Sponsored by Psychiatric Services Aargau AG · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.
Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses and the clinical ratings made by the staff members of the mental hospital under routine everyday conditions.
This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment for crisis intervention leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.
Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses (SCID-I and SCID-II) and the clinical ratings (HoNOS) made by the staff members of the mental hospital under routine everyday conditions.
1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.
This study's enrollment of 707 is above the median of 100 across 1,305 interventional studies indexed under Mental Disorders.
Browse Mental Disorders studies →Psychiatric Services Aargau AG is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients in need of acute psychiatric inpatient care are treated at their houses by mobile treatment teams instead of treatment at mental hospitals whenever home treatment is possible and appropriate.
Other: Home treatment
Patients in need of acute psychiatric inpatient care are treated at a mental hospital.
Other: Treatment As Usual
Patients are treated at home whenever possible and appropriate
Patients are treated at a mental hospital
Number of inpatient days
Time frame: 2 years follow-up
Total days in treatment (inpatient + home treatment)
Time frame: 2 years follow-up
Direct treatment costs
Time frame: 2 years follow-up
Health of the Nation Outcome Scales (HoNOS)
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Time frame: Intake and discharge from treatment episode (expected average of 4 weeks)
Brief Symptom Checklist (BSCL)
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Time frame: Intake and discharge from treatment episode (expected average of 4 weeks)
Perceptions of Care-18
Participants will be assessed at discharge from hospital, after an expected average of 4 weeks.
Time frame: Discharge from treatment episode (expected average of 4 weeks)
Satisfaction of patients' relatives
Relatives' satisfaction will be assessed with an adapted version of the Perceptions of Care-18 questionnaire at discharge of the patients from hospital, after an expected average of 4 weeks. The proportion of satisfied relatives will be reported for both study arms.
Time frame: Discharge from treatment episode (expected average of 4 weeks)
Number of rehospitalizations per patient
Time frame: 2 years follow-up
Number of patients with adverse events
E.g. suicide or attempted suicide.
Time frame: 2 years follow-up
Ran from Apr 2015 to primary completion in Apr 2018, 36 months.
Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's 36 months is above that.
Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Psychiatric Services Aargau AG